Nava Siegelmann-Danieli

Summary

Country: USA

Publications

  1. ncbi [Molecular portrait of breast cancer with sub-classification of breast tumor]
    Nava Siegelmann-Danieli
    Maccabi Healthcare Services, Haifa
    Harefuah 146:48-52, 77-8. 2007
  2. ncbi Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach
    Nava Siegelmann-Danieli
    Department of Hematology and Oncology, Geisinger Medical Center, Danville, PA, USA
    Clin Breast Cancer 7:59-66. 2006
  3. ncbi P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure
    Nava Siegelmann-Danieli
    Geisinger Medical Center, Danville, Pennsylvania, USA
    Tumori 91:346-50. 2005
  4. ncbi Primary pure squamous cell carcinoma of the breast
    Nava Siegelmann-Danieli
    Department of Hematology and Oncology, Penn State Geisinger Medical Center, Danville, PA 17822 2001, USA
    Clin Breast Cancer 6:270-2. 2005
  5. ncbi Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features
    Nava Siegelmann-Danieli
    Department of Hematology and Oncology, Geisinger Medical Center, Danville, PA 19822 2001, USA
    Ann Surg Oncol 10:1031-8. 2003
  6. ncbi Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer development
    Nava Siegelmann-Danieli
    Division of Population Science, Fox Chase Center, Philadelphia, PA, USA
    Oncology 62:39-45. 2002
  7. ncbi Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines
    Mingyue Lun
    Weis Center for Research, Geisinger Medical Center, Danville, Pennsylvania 17822, USA
    Ann Clin Lab Sci 35:15-24. 2005
  8. ncbi [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter]
    Nava Siegelmann-Danieli
    Geisinger Medical Center, Danville, PA, USA
    Harefuah 143:753-6, 764. 2004
  9. ncbi Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy
    Ping L Zhang
    Department of Laboratory Medicine, Geisinger Clinic, Danville, Pennsylvania 17822, USA
    Ann Clin Lab Sci 34:263-70. 2004
  10. ncbi Cystic-appearing pleural metastasis in a patient with recurrent phyllodes tumor
    Ion D Bucaloiu
    Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA
    Breast J 11:482. 2005

Collaborators

Detail Information

Publications13

  1. ncbi [Molecular portrait of breast cancer with sub-classification of breast tumor]
    Nava Siegelmann-Danieli
    Maccabi Healthcare Services, Haifa
    Harefuah 146:48-52, 77-8. 2007
    ..Benefits and limitations of those methods and future directions are discussed...
  2. ncbi Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach
    Nava Siegelmann-Danieli
    Department of Hematology and Oncology, Geisinger Medical Center, Danville, PA, USA
    Clin Breast Cancer 7:59-66. 2006
    ..The current work assessed the independent contributions of age, comorbidities, tumor features, and treatment approach to the outcome of elderly patients with breast cancer...
  3. ncbi P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure
    Nava Siegelmann-Danieli
    Geisinger Medical Center, Danville, Pennsylvania, USA
    Tumori 91:346-50. 2005
    ....
  4. ncbi Primary pure squamous cell carcinoma of the breast
    Nava Siegelmann-Danieli
    Department of Hematology and Oncology, Penn State Geisinger Medical Center, Danville, PA 17822 2001, USA
    Clin Breast Cancer 6:270-2. 2005
    ....
  5. ncbi Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features
    Nava Siegelmann-Danieli
    Department of Hematology and Oncology, Geisinger Medical Center, Danville, PA 19822 2001, USA
    Ann Surg Oncol 10:1031-8. 2003
    ..Fertility drug therapy (FDT) induces supraphysiologic endogenous estrogen production and might transiently increase breast cancer risk. Tumors developing following FDT exposure have not been extensively studied...
  6. ncbi Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer development
    Nava Siegelmann-Danieli
    Division of Population Science, Fox Chase Center, Philadelphia, PA, USA
    Oncology 62:39-45. 2002
    ..NQO1 results suggest that different quinones (possibly estrogenic quinone metabolites) might affect the histological development of breast tumors...
  7. ncbi Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines
    Mingyue Lun
    Weis Center for Research, Geisinger Medical Center, Danville, Pennsylvania 17822, USA
    Ann Clin Lab Sci 35:15-24. 2005
    ..We propose that this proliferative inhibition is variably associated with blocking p-NF-kappaB function by upregulation of nuclear I-kappaB, stabilization of p53, and induction of p21WAF1...
  8. ncbi [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter]
    Nava Siegelmann-Danieli
    Geisinger Medical Center, Danville, PA, USA
    Harefuah 143:753-6, 764. 2004
    ..Physicians treating breast cancer survivors for severe menopausal symptoms should present study results and alternative non-hormonal treatment options to allow patients optimized consented treatment decisions...
  9. ncbi Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy
    Ping L Zhang
    Department of Laboratory Medicine, Geisinger Clinic, Danville, Pennsylvania 17822, USA
    Ann Clin Lab Sci 34:263-70. 2004
    ..Combinatorial therapies directed against other signaling pathways, not dependent upon ras, may be required to overcome such resistance...
  10. ncbi Cystic-appearing pleural metastasis in a patient with recurrent phyllodes tumor
    Ion D Bucaloiu
    Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA
    Breast J 11:482. 2005
  11. ncbi Complete response of brain metastases originating in breast cancer to capecitabine therapy
    Nava Siegelmann-Danieli
    Department of Hematology and Oncology, Geisinger Medical Center, Danville, PA, USA
    Isr Med Assoc J 5:833-4. 2003
  12. ncbi [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter]
    Nava Siegelmann-Danieli
    Assaf Harofeh Medical Center, Zerifin
    Harefuah 141:994-6, 1008. 2002
    ..For women with milder symptoms or those who are not interested in HRT, other treatment options should be outlined. The policy should be updated according to future publication of results from ongoing randomized prospective studies...
  13. doi Orbital metastasis as the presenting symptom of extensive stage small cell lung cancer
    Michelle Henning
    Department of Internal Medicine, Geisinger Medical Cancer, Danville PA, USA
    Eur J Intern Med 19:65-6. 2008
    ..The prognosis is grim, and with the exception of rare cases secondary to hormone-responsive tumors, the majority of patients succumb to their disease within a year of diagnosis...